TEL AVIV, Israel, March 06, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd (CMMB). (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback